Price Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Price Wealth’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$14K	Hold	225	–	–	﹤0.01%	235
2020 Q2	$13K	Buy	225 +198	+733%	+$11.8K	﹤0.01%	147
2020 Q1	$2K	Sell	27 -155	-85%	-$9.47K	﹤0.01%	236
2019 Q4	$12K	Buy	+182	New	+$10.4K	﹤0.01%	153
2019 Q1	–	Sell	-320	Closed	-$17K	–	140
2018 Q4	$17K	Buy	320 +60	+23%	+$3.22K	0.01%	115
2018 Q3	$16K	Sell	260 -773	-75%	-$45.9K	0.01%	115
2018 Q2	$57K	Buy	1,033 +453	+78%	+$24.5K	0.02%	105
2018 Q1	$37K	Sell	580 -60	-9%	-$3.86K	0.02%	89
2017 Q4	$39K	Buy	+640	New	+$40K	0.03%	68

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Price Wealth's BMY Position: Q3 2020 in Review

Price Wealth held its Bristol-Myers Squibb (BMY) position steady in Q3 2020 at 225 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #235.

Price Wealth first reported a position in BMY in Q4 2017 and has held it in 9 quarters since. The position peaked at $57K in Q2 2018. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

Price Wealth held 225 shares of Bristol-Myers Squibb worth $14K as of Q3 2020.
Price Wealth left its Bristol-Myers Squibb share count unchanged in Q3 2020.
Bristol-Myers Squibb made up ﹤0.01% of Price Wealth's portfolio in Q3 2020, its #235 holding.
Price Wealth first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 9 quarters since.
Price Wealth's Bristol-Myers Squibb position peaked at $57K in Q2 2018.
2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.